EN
HI
Remus Pharmaceuticals Chart
Remus Pharmaceuticals Share Key Metrics
Volume
2100.00
Market Cap
836.61 CR
LTQ@LTP
100@715.00
ATP
721.02
Var Margin
53.5 %
Circuit Range
568-851.9
Delivery %
68.12 %
Value
15.14 L
ASM/GSM
No
Market Lot
100
Summary
Remus Pharmaceuticals share price is ₹715 as of 2 Jun, 2026. The stock Remus Pharmaceuticals intraday movement has stayed between ₹715.00 and ₹729.70, while on a 52-week basis,Remus Pharmaceuticals price 52 week high is ₹1069.98 & its 52 week low is ₹580.00.
In terms of trading activity, Remus Pharmaceuticals has recorded a volume of 2100 shares, The Remus Pharmaceuticals has a market cap of ₹11784000 CR. The stock’s Average Traded Price (ATP) stands at ₹721.02, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 100 @ ₹715.00.
Remus Pharmaceuticals operates within a circuit range of ₹568.00 – ₹851.90, with a Value of ₹15.14 L. The Delivery Percentage for the day is 68.12%. Additionally, Remus Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 100.
Remus Pharmaceuticals Fundamentals
View MoreP/E Ratio
22.18
P/B Ratio
2.34
Div. Yield
0.14
Sector P/E
40.7
Sector P/B
2.16
Sec. Div. Yield
78.54
Remus Pharmaceuticals Resistance and Support
Pivot 709.23
Resistance
First Resistance
738.21
Second Resistance
766.48
Third Resistance
795.46
Support
First Support
680.96
Second Support
651.98
Third Support
623.71
Remus Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-20 | Audited Results |
| 2025-11-10 | Quarterly Results & Interim Dividend |
| 2025-05-17 | Audited Results |
Remus Pharmaceuticals News
SMS Pharmaceuticals Limited
SMS Pharma reported strong FY26 financial results, with revenue growing 13% to Rs.887 crores and net profit rising 47% to Rs.102 crores. The company also provided a positive outlook, guiding for 15% revenue growth and a 20% EBITDA margin in FY27.
May 30 2026 13:03:23
Remus Pharmaceuticals Limited
Remus Pharmaceuticals reported strong H2 FY26 performance with consolidated revenue growing 30% YoY to Rs.453 cr and net profit increasing 20% YoY to Rs.25 cr. The company highlighted strategic market expansion and new product filings.
May 28 2026 15:03:02
Read More
Remus Pharmaceuticals Management
| Name | Position |
|---|---|
| Deval Bakulkumar Patel | Company Secretary & Compliance Officer |
| Arpit Deepakkumar Shah | Managing Director |
Remus Pharmaceuticals Similar Stocks
Kokuyo Camlin Ltd.
83.58
2.45 (3.02%)
Cellecor Gadgets Ltd.
37.40
-1.45 (3.73%)
Dhunseri Ventures Ltd.
237.93
-2.13 (0.89%)
Ecos (India) Mobility & Hospitality Ltd.
128.30
-6.75 (5.00%)
Krystal Integrated Services Ltd
583.25
4.30 (0.74%)
JITF Infralogistics Ltd.
319.60
2.15 (0.68%)
Arrow Greentech Ltd.
564.60
19.05 (3.49%)
TAC Infosec Ltd.
385.20
14.75 (3.98%)
Remus Pharmaceuticals FAQs
The Buying Price of Remus Pharmaceuticals share is 715 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Remus Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Remus Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Remus Pharmaceuticals shares is 22.18. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Remus Pharmaceuticals shares is 2.34. Useful to assess the stock's value relative to its book value.
To assess Remus Pharmaceuticals’s valuation compare Sector P/E, P/B which are 40.7 & 2.16 with sector averages, along with growth rates and financial metrics.
The Market Cap of Remus Pharmaceuticals is 836.61 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Remus Pharmaceuticals share price is 1069.98 & 580.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Remus Pharmaceuticals belongs to the Miscellaneous sector.
